Literature DB >> 23675657

Hepatitis C in the United States.

Scott D Holmberg1, Philip R Spradling, Anne C Moorman, Maxine M Denniston.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23675657      PMCID： PMC5672915          DOI： 10.1056/NEJMp1302973

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

Authors:  Philip R Spradling; Loralee Rupp; Anne C Moorman; Mei Lu; Eyasu H Teshale; Stuart C Gordon; Cynthia Nakasato; Joseph A Boscarino; Emily M Henkle; David R Nerenz; Maxine M Denniston; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-08-08       Impact factor: 9.079

2.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

3.  Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.

Authors:  Anne C Moorman; Stuart C Gordon; Loralee B Rupp; Philip R Spradling; Eyasu H Teshale; Mei Lu; David R Nerenz; Cynthia C Nakasato; Joseph A Boscarino; Emily M Henkle; Nancy J Oja-Tebbe; Jian Xing; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

4.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391
  5 in total
  146 in total

1.  Ledipasvir/Sofosbuvir.

Authors:  Dennis J Cada; Danial E Baker; Ross Jason Bindler
Journal:  Hosp Pharm       Date:  2015-03

Review 2.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

3.  Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.

Authors:  Marissa M Maier; David B Ross; Maggie Chartier; Pamela S Belperio; Lisa I Backus
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

4.  Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer.

Authors:  M Walker; H B El-Serag; Y Sada; S Mittal; J Ying; Z Duan; P Richardson; J A Davila; F Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2016-01-19       Impact factor: 8.171

Review 5.  Hepatitis C virus: an overview for dental health care providers.

Authors:  R Monina Klevens; Anne C Moorman
Journal:  J Am Dent Assoc       Date:  2013-12       Impact factor: 3.634

6.  The ongoing debate of who to treat for chronic hepatitis C virus.

Authors:  Marc G Ghany
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

7.  Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

Authors:  Lisa N Wasilewski; Stuart C Ray; Justin R Bailey
Journal:  J Gen Virol       Date:  2016-09-21       Impact factor: 3.891

8.  Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.

Authors:  Mary Thomson; Monica A Konerman; Hetal Choxi; Anna S F Lok
Journal:  Dig Dis Sci       Date:  2016-03-08       Impact factor: 3.199

9.  Frontiers in the treatment of hepatitis C virus infection.

Authors:  Joseph Ahn; Steven L Flamm
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

10.  Integrative genomic analysis of mouse and human hepatocellular carcinoma.

Authors:  Michelle Dow; Rachel M Pyke; Brian Y Tsui; Ludmil B Alexandrov; Hayato Nakagawa; Koji Taniguchi; Ekihiro Seki; Olivier Harismendy; Shabnam Shalapour; Michael Karin; Hannah Carter; Joan Font-Burgada
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.